Do not stop Wegovy without consulting your healthcare provider
The study, called STEP 1, included 1,961 adults with a body mass index (BMI) of 27 or higher with at least one weight-related health condition, or a BMI of 30 or higher, without diabetes
Before writing your headache off as a side effect of semaglutide, check your blood sugar levels
By understanding its mechanisms, efficacy, safety considerations, and real-world implications, healthcare providers and patients can make informed decisions regarding its use in the management of obesity
Their programs are affordable, their staff is thorough and warm, and they go above and beyond in all aspects
Your clinician will assess whether this dose is suitable for you